Interestingly, EVs isolated from breast cancer model mouse tumor cells have been shown to induce the differentiation of bone marrow-derived suppressor cells (MDSCs), which promote tumor progression, via the prostaglandin E2 (PGE2) and TGF-β pathways (Xiang et al., 2009). Here, TGFB1 is linked to breast carcinoma.